{"id":197762,"name":"CAMERON COMPANIES","slug":"cameron-companies","state":"PA","country":"United States of America","description":"government affairs consulting","totalSpending":140000,"filings":21,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":40000},{"year":2020,"income":40000},{"year":2021,"income":20000},{"year":2022,"income":0}],"issues":["MMM","BUD"],"firms":["CHRISTOPHER MOYER"],"lobbyists":["CHRISTOPHER MOYER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["FY 2018 Continuing Resolution, budget agreement, the omnibus FY 2018 appropriations bill and the President's FY 2019 Budget as they relate to site neutrality payment policies and funding the National ","FY 2018 Continuing Resolution, budget agreement, the omnibus FY 2018 appropriations bill and the President's FY 2019 Budget as they relate to site neutrality payment policies and funding the National ","FY 2018 Continuing Resolution, budget agreement, the omnibus FY 2018 appropriations bill and the President's FY 2019 Budget as they relate to site neutrality payment policies and funding the National ","FY 2018 Continuing Resolution, budget agreement, the omnibus FY 2018 appropriations bill and the President's FY 2019 Budget as they relate to site neutrality payment policies and funding the National ","The President's FY 2020 Budget as it relates to site neutral payment policies and funding for the National Institutes of Health, monitored the introduction of drug pricing legislation for its potentia"],"years":[2018,2019,2020,2021,2022]}